HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dial Acquires Revlon's $53 Mil. Plusbelle Hair Care Line

This article was originally published in The Rose Sheet

Executive Summary

Revlon is selling a second piece of its Latin American business portfolio, Plusbelle value-priced shampoos and conditioners, to Dial for $46.5 mil. in cash under an agreement announced March 29. The deal is scheduled to close early May.

You may also be interested in...



Revlon Product Launches Fuel Momentum In Second Quarter

Revlon new product introductions helped to build sales momentum in the second quarter with consolidated net revenues up a slight 1.6% to $330.4 mil. on an ongoing operational basis, CEO Jeffrey Nugent told analysts during an Aug. 2 conference call.

Revlon Product Launches Fuel Momentum In Second Quarter

Revlon new product introductions helped to build sales momentum in the second quarter with consolidated net revenues up a slight 1.6% to $330.4 mil. on an ongoing operational basis, CEO Jeffrey Nugent told analysts during an Aug. 2 conference call.

Dial Specialty Personal Care Reduced By 42%, Nature's Accents Discontinued

Dial Corp. is shedding almost half its Specialty Personal Care SKUs, including the unprofitable Nature's Accents line, under a strategic plan to be implemented by newly appointed CEO Herbert Baum, the exec announced at an investor meeting in New York City Sept. 22.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007839

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel